Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2004 1
2005 3
2006 4
2007 11
2008 18
2009 16
2010 15
2011 18
2012 18
2013 24
2014 20
2015 22
2016 20
2017 9
2018 13
2019 10
2020 12
2021 19
2022 18
2023 15
2024 14
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
Kwatra SG, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Lynde C, De Bruin-Weller MS, Nahm WK, Sauder M, Gharib R, Barbarot S, Szepietowski JC, Conrad C, Fleischer A, Laquer VT, Misery L, Serra-Baldrich E, Lapeere H, Ahmad F, Jabbar Lopez ZK, Piketty C, Ständer S; OLYMPIA 2 Investigators. Kwatra SG, et al. N Engl J Med. 2023 Oct 26;389(17):1579-1589. doi: 10.1056/NEJMoa2301333. N Engl J Med. 2023. PMID: 37888917 Clinical Trial.
Modularity-based mathematical modeling of ligand inter-nanocluster connectivity for unraveling reversible stem cell regulation.
Kim C, Kang N, Min S, Thangam R, Lee S, Hong H, Kim K, Kim SY, Kim D, Rha H, Tag KR, Lee HJ, Singh N, Jeong D, Hwang J, Kim Y, Park S, Lee H, Kim T, Son SW, Park S, Karamikamkar S, Zhu Y, Hassani Najafabadi A, Chu Z, Sun W, Zhao P, Zhang K, Bian L, Song HC, Park SG, Kim JS, Lee SY, Ahn JP, Kim HK, Zhang YS, Kang H. Kim C, et al. Among authors: son sw. Nat Commun. 2024 Dec 23;15(1):10665. doi: 10.1038/s41467-024-54557-8. Nat Commun. 2024. PMID: 39715783 Free PMC article.
Phase 1/2 trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis.
Seo HM, Lew BL, Lee YW, Son SW, Park CO, Park YL, Baek JO, Shin MK, Kim DH, Lee DH, Jang YH, Ko HC, Na CH, Seo YJ, Ham DS, Kim DJ, Choi GS. Seo HM, et al. Among authors: son sw. J Allergy Clin Immunol. 2024 Oct;154(4):965-973. doi: 10.1016/j.jaci.2024.06.013. Epub 2024 Jun 27. J Allergy Clin Immunol. 2024. PMID: 38944393 Free article. Clinical Trial.
276 results